61
Participants
Start Date
November 30, 2013
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
ADT
Brexpiprazole
Behavioral Medical Research of Staten Island, Staten Island
Lehigh Center for Clinical Research, Allentown
Pharmasite Research, Baltimore
Richard H. Weisler, MD, PA, Raleigh
Carman Research, Smyrna
Clinical Neuroscience Solutions Pharmacology, Orlando
Research Strategies of Memphis, LLC, Memphis
Goldpoint Clinical Research, Indianapolis
Alpine Clinic, Lafayette
Rochester Center for Behavioral Medicine, Rochester Hills
St. Louis Clinical Trials, St Louis
Cutting Edge Research Group, Oklahoma City
Future Search Trials of Dallas, LP, Dallas
Viking Clinical Research, Ltd., Temecula
Collaborative NeuroScience Network, Inc., Garden Grove
Oregon Center for Clinical Investigations, Inc., Portland
Oregon Center for Clinical Investigations, Inc., Salem
Frontier Institute, Spokane
Boston Clinical Trials, Boston
Coastal Research Associates, Inc., Weymouth
Center for Emotional Fitness, Cherry Hill
Midwest Clinical Research Center MCRC, Dayton
Lincoln Research, LLC, Lincoln
NeuropsychiatricAssociates, Woodstock
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY